ArticleAmerican journal of respiratory and critical care medicine2012

MUC5B and pulmonary fibrosis, omalizumab for severe allergic asthma, and interstitial lung abnormalities in smokers with emphysema.

Divay Chandra et al.PubMed ↗Publisher ↗

No numbers read from the abstract.